teknova.com (TKNO): Rentabilitas operasi

Alpha Teknova Inc (TKNO) - logo korporat

Partnerships with gene therapy developers strengthen the position of Alpha Teknova, Inc. (TKNO). Operating margin dynamics demonstrate pricing power, while -31.60 captures a new level. The financial base relies on multi-year raw material supply contracts and the deep integration of customized buffer solutions into customers' technical processes, which securely protects the company's share of the biotechnology market.

TKNO - Rasio bathi operasi Teknova ing rentang 04.07.2022 - 19.11.2026

Rincian analitis lan laporan data perusahaan teknova.com (TKNO)

- rega saham lan konsensus proyeksi valuasi:
Ringkesan analisis perusahaan:TKNO, Teknova
Produk dadi Alpha Teknova, Inc.

Capital must distinguish fundamentally resilient assets from speculative instruments. Stable demand in the life sciences sector and the high qualification of Alpha Teknova, Inc. (TKNO) personnel ensure operational production clarity. This operating profit-to-revenue ratio reflects the efficiency of cash generation from core activities before accounting for financial obligations and taxes. The trend of this metric allows for a comparison of internal profitability against market capitalization. A steady positive trend confirms the viability of the business model.

Karo sapa Alpha Teknova, Inc. saingan

ISRG (intuitive.com) - Margin operasi|Rentabilitas dodolan miturut bathi operasi DHR (Danaher Corp.)|Margin dodolan operasi BDX (Becton, Dickinson and Company)|Rasio bathi operasi STE|Rentabilitas operasi West Pharma WST|Rentabilitas kegiatan operasi Baxter (BAX)|MASI - Rentabilitas operasi|Rentabilitas kegiatan operasi Stevanato Group Corp STVN|TFX: Margin operasi|Margin dodolan operasi Merit Medical Systems|Rentabilitas operasi Envista Holdings Corp|Margin dodolan operasi ICU Medical Corp (ICUI)|Rentabilitas operasi DENTSPLY SIRONA Inc. (XRAY)|Margin dodolan operasi LeMaitre LMAT|Margin operasi ATRC (atricure.com)|Margin operasi staar.com STAA|NAGE - Rentabilitas operasi|Rentabilitas kegiatan operasi ZimVie ZIMV|ANGO: Margin operasi|Cerus Corp - Tingkat bathi operasi|MGRM (Monogram Orthopedics Inc.) - Margin operasi|STSS: Tingkat bathi operasi|Margin dodolan operasi INFU (InfuSystem Holdings)|Utah Medical Products, Inc. - Rentabilitas dodolan miturut bathi operasi|Margin operasi KRMD (korumedical.com)|Rentabilitas kegiatan operasi Nyxoah, S.A. (NYXH)|MBOT - Rentabilitas operasi|PDEX (Pro-Dex, Inc.) - Rentabilitas dodolan miturut bathi operasi|ZTEK (Zentek Ltd) - Margin dodolan operasi|ELUT - Rentabilitas kegiatan operasi|MLSS (Milestone Scientific Corporation) - Margin operasi|Rentabilitas dodolan miturut bathi operasi NXGL (NEXGEL, Inc.)|Margin operasi RVP|Margin dodolan operasi Harvard Bioscience HBIO|Margin operasi FEMY (Femasys Corporation)|MHUA - Margin dodolan operasi|POAI - Rentabilitas operasi|Callan JMB (CJMB) - Margin dodolan operasi|ATRI: Margin operasi|NURO - Rentabilitas kegiatan operasi